Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Afabicin diolamine in Renal Insufficiency: NCT07758608 Clinical Landscape Report 2026
16 September 2026
NCT07758608 clinical landscape for Renal Insufficiency: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Florquinitau F18 in Alzheimer Disease: NCT07758660 Clinical Landscape Report 2026
16 September 2026
NCT07758660 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ATV-Abeta(Denali Therapeutics) in Alzheimer Disease: NCT07758595 Clinical Landscape Report 2026
16 September 2026
NCT07758595 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SHR-7590 in Colitis, Ulcerative: NCT07758101 Clinical Landscape Report 2026
16 September 2026
NCT07758101 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AgenT-797 in Myeloid Tumor: NCT07758218 Clinical Landscape Report 2026
16 September 2026
NCT07758218 clinical landscape for Myeloid Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cladribine in Relapsing acute myeloid leukemia: NCT07757672 Clinical Landscape Report 2026
16 September 2026
NCT07757672 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Buntanetap in Alzheimer Disease: NCT07757204 Clinical Landscape Report 2026
16 September 2026
NCT07757204 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
tPA/HisproUK(Thrombolytic Science International LLC) in Gastrooesophageal junction cancer: NCT07757191 Clinical Landscape Report 2026
16 September 2026
NCT07757191 clinical landscape for Gastrooesophageal junction cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Flurpiridaz F 18 in Cardiotoxicity: NCT07761910 Clinical Landscape Report 2026
16 September 2026
NCT07761910 clinical landscape for Cardiotoxicity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sintilimab in Hepatocellular Carcinoma: NCT07761286 Clinical Landscape Report 2026
16 September 2026
NCT07761286 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HRS-7085 in Colitis, Ulcerative: NCT07760831 Clinical Landscape Report 2026
16 September 2026
NCT07760831 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
QLS1510 in Inflammatory Bowel Diseases: NCT07760077 Clinical Landscape Report 2026
16 September 2026
NCT07760077 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.